ATE429211T1 - Flüssige trägerformulierungen mit hohem wassergehalt - Google Patents
Flüssige trägerformulierungen mit hohem wassergehaltInfo
- Publication number
- ATE429211T1 ATE429211T1 AT03716645T AT03716645T ATE429211T1 AT E429211 T1 ATE429211 T1 AT E429211T1 AT 03716645 T AT03716645 T AT 03716645T AT 03716645 T AT03716645 T AT 03716645T AT E429211 T1 ATE429211 T1 AT E429211T1
- Authority
- AT
- Austria
- Prior art keywords
- liquid carrier
- water content
- high water
- carrier vehicle
- liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/104,662 US20030185762A1 (en) | 2002-03-22 | 2002-03-22 | Highly aqueous liquid carrier formulations |
PCT/US2003/008157 WO2003082242A2 (en) | 2002-03-22 | 2003-03-17 | Highly aqueous liquid carrier formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE429211T1 true ATE429211T1 (de) | 2009-05-15 |
Family
ID=28452384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03716645T ATE429211T1 (de) | 2002-03-22 | 2003-03-17 | Flüssige trägerformulierungen mit hohem wassergehalt |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030185762A1 (de) |
EP (1) | EP1487409B1 (de) |
AT (1) | ATE429211T1 (de) |
AU (1) | AU2003220346A1 (de) |
CA (1) | CA2480123C (de) |
DE (1) | DE60327310D1 (de) |
WO (1) | WO2003082242A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005501810A (ja) | 2001-03-22 | 2005-01-20 | バテル メモリアル インスティチュート | ポリマーおよび懸濁粒子を含有する電気流体力学的噴霧用の液体形成物 |
CN101151048A (zh) * | 2004-05-10 | 2008-03-26 | 纳斯泰克制药公司 | 增强甲状旁腺激素粘膜递送的组合物和方法 |
AU2005284706B2 (en) * | 2004-09-14 | 2011-02-24 | Battelle Memorial Institute | Highly-aqueous non-respirable aerosols containing biologically-active ingredients method of making and device therefor |
EP2534957B1 (de) | 2007-12-14 | 2015-05-27 | AeroDesigns, Inc | Abgabe von Aerosol-sprühbaren Produkten |
US20110174304A1 (en) * | 2010-01-21 | 2011-07-21 | Triplett Ii Michael D | Electrohydrodynamic aerosolization device having a time varying voltage |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3815221C2 (de) * | 1988-05-04 | 1995-06-29 | Gradinger F Hermes Pharma | Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen |
US5215739A (en) * | 1989-04-05 | 1993-06-01 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
EP0444778A1 (de) * | 1990-02-14 | 1991-09-04 | Alcon Laboratories, Inc. | Verwendung von Alkylsacchariden zur Förderung der Penetration von Arzneistoffen |
US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
AU2001244391B9 (en) * | 2000-04-03 | 2006-10-05 | Ventaira Pharmaceuticals, Inc. | Devices and formulations |
US6339107B1 (en) * | 2000-08-02 | 2002-01-15 | Syntex (U.S.A.) Llc | Methods for treatment of Emphysema using 13-cis retinoic acid |
JP2004526674A (ja) * | 2000-12-01 | 2004-09-02 | バテル・メモリアル・インスティテュート | 液体処方物中における生体分子の安定化のための方法 |
-
2002
- 2002-03-22 US US10/104,662 patent/US20030185762A1/en not_active Abandoned
-
2003
- 2003-03-17 CA CA2480123A patent/CA2480123C/en not_active Expired - Fee Related
- 2003-03-17 AU AU2003220346A patent/AU2003220346A1/en not_active Abandoned
- 2003-03-17 AT AT03716645T patent/ATE429211T1/de not_active IP Right Cessation
- 2003-03-17 EP EP03716645A patent/EP1487409B1/de not_active Expired - Lifetime
- 2003-03-17 WO PCT/US2003/008157 patent/WO2003082242A2/en not_active Application Discontinuation
- 2003-03-17 DE DE60327310T patent/DE60327310D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20030185762A1 (en) | 2003-10-02 |
WO2003082242A2 (en) | 2003-10-09 |
EP1487409A2 (de) | 2004-12-22 |
EP1487409B1 (de) | 2009-04-22 |
DE60327310D1 (de) | 2009-06-04 |
WO2003082242A3 (en) | 2003-12-18 |
CA2480123C (en) | 2010-11-30 |
CA2480123A1 (en) | 2003-10-09 |
AU2003220346A1 (en) | 2003-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03004883A (es) | Metodo para la estabilizacion de biomoleculas (por ejemplo, insulina) en formulaciones liquidas. | |
CY1120513T1 (el) | Υψηλης συμπυκνωσης συνθεση μινοξιδιλης | |
DE69523587D1 (de) | Fluticasonpropionat-formulierungen | |
HK1002552A1 (en) | Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions | |
DE60027463D1 (de) | Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon | |
DK1206261T3 (da) | Farmaceutiske præparater, der omfatter clavuansyre eller derivater deraf, til behandlingen af adfærdsmæssige sygdomme | |
AR048017A1 (es) | Composicion y metodo para aumentar la biodisponibilidad | |
ES2129117T3 (es) | Formulaciones en disolucion en forma de aerosol medicinales estabilizadas. | |
TR200103178T2 (tr) | İntegrinlerin reseptörlere bağlanmasını engelleyen karboksilik asit türevleri. | |
EA200100298A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5 | |
BRPI0416743A (pt) | formulação farmacêutica, e, métodos de preparar uma formulação de peptìdeo apropriada para uso em um dispositivo de injeção, para reduzir depósitos em equipamento de produção e no produto final, e para reduzir o entupimento de dispositivos de injeção por uma formulação de peptìdeo | |
ES8607721A1 (es) | Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario. | |
ATE450265T1 (de) | Pharmazeutische mischung zur behandlung von krebs,die dioxolan nukleosidanalogen enthält | |
BG106104A (en) | Method for the treatment of diseases related to increased number of neutrophils or neutrophil overactivation | |
BR112019015596A2 (pt) | Composição farmacêutica adequada para administração tópica e método para tratar ou prevenir doenças ou distúrbios dermatológicos | |
ATE429211T1 (de) | Flüssige trägerformulierungen mit hohem wassergehalt | |
DK1684719T3 (da) | Alfa-1-antitrypsin-sammensætninger og behandlingsfremgangsmåder, der anvender sådanne sammensætninger | |
RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
ATE444739T1 (de) | Polymerzusammensetzung sowie diese enthaltende darreichungsformen | |
PE33396A1 (es) | Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar | |
GB2412066A (en) | Method of reducing toxicity of anticancer agents | |
ES2171749T3 (es) | Composiciones farmaceuticas que contienen inhibidores de la agregacion de plaquetas. | |
FR2754824B1 (fr) | Nouvelle composition contenant du chitosan | |
TH21862A (th) | การรักษาโรคผิวหนังอักเสบ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |